US Anti-Fungal Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : January 2022
  • Region: North America
  • Country: US
  • Report ID : 5030

  • Format: PPT, PDF

US Anti-Fungal Market Analysis: Segmented by Drug Type, Therapeutic Indications, Application – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 5030 Categories: ,

Report Description of the US Anti-Fungal Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for US Anti-Fungal Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the US Anti-Fungal  Market  Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

US Anti-Fungal Market Analysis Executive Summary

Antifungal drugs are commonly used to cure fungal infections due to unclean, unhygienic, and damp environments. Invasion of epithelial tissue by microscopic organisms leads to fungal infections. Systemic fungal infections are caused due to indigestion or inhalation of spores, leading to fungal pneumonia, and diseases like candidiasis, meningitis, mucormycosis, etc., are caused by opportunistic fungus. Although the majority of fungal infections and diseases are commonly non-lethal, they are very uncomfortable to the host, and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms such as inhibiting cell wall formation, cell membrane disruption, and cell division.

Market Size and Key Findings

The US Anti-Fungal Market Analysis size stood at around USD 5.15 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 3.7% during the forecast period.

The Antifungal Drugs Market size in North America is estimated at USD 5.15 billion in 2020. It is further projected to be growing at a CAGR of 3.7% and worth USD xx billion by 2028. In the following years, the market is poised to grow significantly with the rising global population.

Market Dynamics

Market Growth Drivers Analysis

The North American Antifungal drugs market is expected to be driven by the proliferation of contagious diseases, the rising number of fungal infectious diseases such as miconazole and terbinafine. Also, the increased health concerns and expanding government and non-government support for antifungal disorders are expected to drive the market growth rate throughout the forecast period. The adoption of technological advancement in the production of various pharmaceuticals and delivering effective treatment techniques for various infectious diseases around the region is expected to fuel the growth of North America antifungal drugs market. The market is also likely to be aided by increased investment in research & development institutes. Increased cancer rates, a surge in hematopoietic stem cell transplantation, and other immune system-related factors are all driving the growth of the North American antifungal drugs market.

Market Restraints

The concerned associated long-term side effects with the usage of these drugs hamper the market growth in addition antifungal drug demand is also being slowed by variations in the rate of pharmaceutical manufacture. In addition, the scarcity of qualified personnel in the pharmaceutical manufacturing industries, which is the key restraint in the North America antifungal drugs market. However, the economy slows down, with the pandemic being the primary cause of improper government funds to cure these fungal viral infections. Furthermore, the government’s stringent rules and regulations for approving new drugs are the major challenging factor.

COVID-19 impact on “US Anti-Fungal Market”

The COVID-19 pandemic is expected to have a significant impact on the market. As the import and export activities have been restricted due to the lockdown, it is expected to negatively impact the market studied due to shortage and irregular supply of raw materials and finished medical supplies and drugs. However, this might allow local manufacturers to increase their presence in the market. Supply disruption and medicine shortages of medical supplies have been observed in several countries due to the temporary lockdowns of manufacturing sites, export bans, increased demands for medicine for the treatment of COVID-19, and the stockpiling of medicines by individuals.

Competitive Landscape

Key Players

the key players operating in the antifungal drugs market, such as Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck & Co., Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Scynexis Inc., Enzon Pharmaceuticals, Inc., and GlaxoSmithKline Plc.

The other players of the antifungals drugs market include Astellas Pharma, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc. (a subsidiary of Danaher Corporation), Kramer Laboratories, Basilea Pharmaceutical Ltd., Valeant Pharmaceuticals International, Inc., and Tecan Group.

Products in Pipeline

  • In 2019, Mayne Pharma announced the launch of TOLSURA (SUBA-itraconazole) 65mg capsule in the United States.
  • Ibrexafungerp (MK-3118 and SCY-078; developed by Scynexis, Jersey City, NJ, USA) is a first-in-class oral glucan synthase inhibitor.

Notable Recent Deals

In June 2021, Cadila Pharmaceuticals launched a new triazole antifungal drug Posaconazole that is effective against a wide range of invasive fungal diseases. Additionally, the drug has been recommended as a second-line treatment for Mucormycosis.

In June 2021, Scynexis announced the approval of Brexafemme, bu the United States Food and Drug Administration for the treatment of vaginal yeast infections.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

Private plans typically include medical and pharmacy benefits. Drugs used with Durable Medical Equipment (DME) are often covered under the pharmacy benefit. Physician-administered drugs, regardless of formulation, are typically covered and paid under the medical benefit. FDA approval is typically a prerequisite for coverage, but private plans have a greater flexibility than public plans in defining the benefit category and placement of drugs on formularies, as well as adopting utilization controls.

1. Report Description of the US Anti-Fungal Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. US Anti-Fungal Market Analysis Executive Summary
2.1 US Anti-Fungal Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of US Anti-Fungal Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 The rising number of fungal infectious diseases
3.1.2 The adoption of technological advancement
3.1.3 Increased investment in research & development institutes
3.2 Market Restraints Analysis
3.2.1 Long-term side effects with the usage
3.2.2 Antifungal drug demand is also being slowed by variations
3.2.3 The scarcity of qualified personnel
3.3 Covid-19 Market Impact Analysis
4. US Anti-Fungal Market Segmentation
4.1 By Drug Type:
4.1.1 Echinocandins
4.1.2 Azoles
4.1.3 Polyenes
4.1.4 Allylamines
4.1.5 Others
4.2 By Therapeutic Indications:
4.2.1 Aspergillosis
4.2.2 Dermatophytosis
4.2.3 Candidiasis
4.2.4 Others
4.3 By Application:
4.3.1 Powders
4.3.2 Ointments
4.3.3 Drugs
4.3.4 Pastes
5. US Anti-Fungal Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives Anti-Fungal Market
6.4 Notable recent deals in Anti-Fungal Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Alternaria Company overview
Product & Services, Strategies & Financials
7.2 Pfizer Company overview
Product & Services, Strategies & Financials
7.3 GlaxoSmithKline Gilead Company overview
Product & Services, Strategies & Financials
7.4 Novartis Company overview
Product & Services, Strategies & Financials
7.5 Merck & Company overview
Product & Services, Strategies & Financials
7.6 Bayer Healthcare Company overview
Product & Services, Strategies & Financials
7.7 Abbott company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Anti-Fungal market
9.2 Future Opportunities
10. Strategic Recommendations

US Anti-Fungal Market Analysis Segmentation

By Drug Type:

Based on Drug type, the market is segmented into azoles, echinocandins, polyenes, and allylamines. Azoles are considered to be the leading segment owing to its fungicidal properties and increased revenue generation in 2019. Azoles are systemic antifungal drugs that include fluconazole, ketoconazole, and others which are highly recommended for fungal infection treatment, thereby up scaling the market.

By Therapeutic Indications:

In terms of indication, the market is segmented into dermatophytosis, aspergillosis, candidiasis, and others. Dermatophytosis is a non-fatal superficial infection on skin. Dermatophytosis is anticipated to dominate the market owing to an increase in prevalence of dermatophytosis cases.

By Application:

In terms of Application, it is divided into powders, ointments, drugs, and pastes. Drugs are not only anticipated to remain the dominant segment in the near future but are also projected to grow at the fastest CAGR of 4.2%.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements